Debasish Roychowdhury is Co-founder, Director and CMO of Partner Therapeutics. At T-knife he is an independent Director of the Board. He is a hematologist/oncologist by training with over 15 years of pharmaceutical industry and senior management experiences. This includes CMO at Seragon through the company’s acquisition by Roche, SVP and Head of the Global Oncology Division at Sanofi, VP for Clinical Development at GlaxoSmithKline, and Director of the Oncology global regulatory group at Eli Lilly. Prior to his roles in industry, he served as faculty member at the University of Cincinnati.
Current role